Board of Scientific Counselors, National Center for Injury Prevention and Control, 24003-24004 [2024-07300]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Notices
land-ports-of-entry/douglascommercial-land-port-of-entry and
https://www.gsa.gov/about-us/regions/
welcome-to-the-pacific-rim-region-9/
land-ports-of-entry/raul-hector-castroland-port-of-entry.
Russell Larson,
Director, Portfolio Management Division,
Pacific Rim Region, Public Buildings Service.
[FR Doc. 2024–07032 Filed 4–4–24; 8:45 am]
BILLING CODE 6820–YF–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meetings
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of five AHRQ
subcommittee meetings.
AGENCY:
The subcommittees listed
below are part of AHRQ’s Health
Services Research Initial Review Group
(IRG) Committee. Grant applications are
to be reviewed and discussed at these
meetings. Each subcommittee meeting
will be closed to the public.
DATES: See below for dates of meetings:
1. Healthcare Research Training (HCRT)
Date: May 16–17, 2024
July 19, 2024
2. Healthcare Safety and Quality
Improvement Research (HSQR)
Date: May 22–23, 2024
3. Healthcare Effectiveness and
Outcomes Research (HEOR)
Date: June 5–6, 2024
4. Healthcare Information Technology
Research (HITR)
Date: June 6–7, 2024
5. Health System and Value Research
(HSVR)
Date: June 13–14, 2024
ADDRESSES: Agency for Healthcare
Research and Quality (Virtual Review),
5600 Fishers Lane, Rockville, Maryland
20857.
FOR FURTHER INFORMATION CONTACT: (To
obtain a roster of members, agenda or
minutes of the non-confidential portions
of the meetings.)
Jenny Griffith, Committee Management
Officer, Division of Policy,
Coordination and Analysis, Office of
Extramural Research Education and
Priority Populations, Agency for
Healthcare Research and Quality
(AHRQ), 5600 Fishers Lane,
Rockville, Maryland 20857,
Telephone (301) 427–1557
SUPPLEMENTARY INFORMATION: In
accordance with the Federal Advisory
Committee Act, 5 U.S.C. 1009(a)(2),
AHRQ announces meetings of the
above-listed scientific peer review
groups, which are subcommittees of
AHRQ’s Health Services Research Initial
Review Group Committee. The
subcommittee meetings will be closed to
the public in accordance with the
provisions set forth in 5 U.S.C. 1009(d),
5 U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for these meetings are
subject to change as priorities dictate.
Dated: April 2, 2024.
Marquita Cullom,
Associate Director.
[FR Doc. 2024–07295 Filed 4–4–24; 8:45 am]
BILLING CODE 4160–90–P
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:44 Apr 04, 2024
Jkt 262001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of closed meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting for the Board of
Scientific Counselors, National Center
for Injury Prevention and Control (BSC,
NCIPC). This meeting is closed to the
public.
DATES: The meeting will be held on May
14, 2024, from 10 a.m. to 1 p.m., EDT
(CLOSED).
ADDRESSES: Webinar, Atlanta, Georgia.
FOR FURTHER INFORMATION CONTACT:
Christopher R. Harper, Ph.D.,
Designated Federal Officer, Board of
Scientific Counselors, National Center
for Injury Prevention and Control,
Centers for Disease Control and
Prevention, 4770 Buford Highway NE,
Mailstop S–1069, Atlanta, Georgia
30341. Telephone: (404) 718–8330;
Email: ncipcbsc@cdc.gov.
SUPPLEMENTARY INFORMATION: The
meeting referenced above will be closed
SUMMARY:
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
24003
to the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5, U.S.C., and
the Determination of the Director, Office
of Strategic Business Initiatives, Office
of the Chief Operating Officer, Centers
for Disease Control and Prevention,
pursuant to 5 U.S.C. 1009(d) (Pub. L.
92–463, as amended).
Purpose: The Board of Scientific
Counselors, National Center for Injury
Prevention and Control (BSC, NCIPC)
will: (1) conduct, encourage, cooperate
with, and assist other appropriate public
health authorities, scientific
institutions, and scientists in the
conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes and
strategies related to the prevention of
injury, overdose, and violence; (2) assist
States and other entities in preventing
intentional and unintentional injuries,
and to promote health and well-being;
and (3) make recommendations of grants
and cooperative agreements for research
and prevention activities related to
injury, overdose, and violence. The
BSC, NCIPC makes recommendations
regarding policies, strategies, objectives,
and priorities and reviews progress
toward injury, overdose, and violence
prevention. The Board also provides
advice on the appropriate balance of
intramural and extramural research and
provides guidance on the needs,
structure, progress, and performance of
intramural programs. Further, the Board
provides guidance on extramural
scientific program matters.
Additionally, the Board provides
second-level scientific and
programmatic review of applications for
research grants, cooperative agreements,
and training grants related to injury,
overdose, and violence prevention, and
recommends approval of projects that
merit further consideration for funding
support. The Board also provides
feedback and input on strategic plans,
resources, and priority publications
related to injury, overdose, and violence
prevention.
Matters to be Considered: The closed
meeting will focus on the secondary
peer review of extramural research grant
applications received in response to
three (3) Notices of Funding
Opportunity: RFA–CE–24–013—
‘‘Research Grants to Identify Effective
Community-Based Strategies for
Overdose Prevention’’; RFA–CE–24–
029—‘‘Grants to Support New
Investigators in Conducting Research
Related to Preventing Interpersonal
Violence Impacting Children and
Youth’’; and RFA–CE–24–034—
‘‘Rigorous Evaluation of Policies for
their Impacts on the Primary Prevention
E:\FR\FM\05APN1.SGM
05APN1
24004
Federal Register / Vol. 89, No. 67 / Friday, April 5, 2024 / Notices
of Multiple Forms of Violence.’’ Agenda
items are subject to change as priorities
dictate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
Please note: Submit all comments through
the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to the
address listed above.
[FR Doc. 2024–07300 Filed 4–4–24; 8:45 am]
BILLING CODE 4163–18–P
FOR FURTHER INFORMATION CONTACT:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–24–24EE; Docket No. CDC–2024–
0023]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled DFWED
National Hypothesis Generation and
Investigation Module. The proposed
data collection will define a core set of
standardized data elements and forms
used for outbreak investigations and
surveillance activities for a variety of
enteric illnesses.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:44 Apr 04, 2024
Jkt 262001
CDC must receive written
comments on or before June 4, 2024.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0023 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
DATES:
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
DFWED National Hypothesis
Generation and Investigation Module—
New—National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Division of Foodborne,
Waterborne, and Environmental
Diseases (DFWED) at the Centers for
Disease Control and Prevention (CDC)
aims to protect public health through
the prevention and control of disease,
disability, and death caused by
foodborne, enteric, waterborne, and
environmentally transmitted infections.
To overcome challenges presented by
the changing landscape of enteric
diseases, the need for comprehensive
hypothesis generating questionnaires
focused on a range of settings, activities,
and potential modes of transmission are
essential to guide prevention and
control activities. The submitted forms
standardize hypothesis generating
instruments used during enteric disease
outbreak investigations and
surveillance. This includes foodborne,
waterborne, and zoonotic disease
surveillance and outbreak
investigations. In addition, enhanced
surveillance for antibiotic resistant
isolates is also included in this package.
CDC requests OMB approval for an
estimated 5,852 annual burden hours.
There is no cost to respondents other
than their time to participate.
E:\FR\FM\05APN1.SGM
05APN1
]]>Agencies
[Federal Register Volume 89, Number 67 (Friday, April 5, 2024)]
[Notices]
[Pages 24003-24004]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-07300]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of closed meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting for the Board of Scientific Counselors, National
Center for Injury Prevention and Control (BSC, NCIPC). This meeting is
closed to the public.
DATES: The meeting will be held on May 14, 2024, from 10 a.m. to 1
p.m., EDT (CLOSED).
ADDRESSES: Webinar, Atlanta, Georgia.
FOR FURTHER INFORMATION CONTACT: Christopher R. Harper, Ph.D.,
Designated Federal Officer, Board of Scientific Counselors, National
Center for Injury Prevention and Control, Centers for Disease Control
and Prevention, 4770 Buford Highway NE, Mailstop S-1069, Atlanta,
Georgia 30341. Telephone: (404) 718-8330; Email: [email protected].
SUPPLEMENTARY INFORMATION: The meeting referenced above will be closed
to the public in accordance with provisions set forth in Section
552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention, pursuant
to 5 U.S.C. 1009(d) (Pub. L. 92-463, as amended).
Purpose: The Board of Scientific Counselors, National Center for
Injury Prevention and Control (BSC, NCIPC) will: (1) conduct,
encourage, cooperate with, and assist other appropriate public health
authorities, scientific institutions, and scientists in the conduct of
research, investigations, experiments, demonstrations, and studies
relating to the causes and strategies related to the prevention of
injury, overdose, and violence; (2) assist States and other entities in
preventing intentional and unintentional injuries, and to promote
health and well-being; and (3) make recommendations of grants and
cooperative agreements for research and prevention activities related
to injury, overdose, and violence. The BSC, NCIPC makes recommendations
regarding policies, strategies, objectives, and priorities and reviews
progress toward injury, overdose, and violence prevention. The Board
also provides advice on the appropriate balance of intramural and
extramural research and provides guidance on the needs, structure,
progress, and performance of intramural programs. Further, the Board
provides guidance on extramural scientific program matters.
Additionally, the Board provides second-level scientific and
programmatic review of applications for research grants, cooperative
agreements, and training grants related to injury, overdose, and
violence prevention, and recommends approval of projects that merit
further consideration for funding support. The Board also provides
feedback and input on strategic plans, resources, and priority
publications related to injury, overdose, and violence prevention.
Matters to be Considered: The closed meeting will focus on the
secondary peer review of extramural research grant applications
received in response to three (3) Notices of Funding Opportunity: RFA-
CE-24-013--``Research Grants to Identify Effective Community-Based
Strategies for Overdose Prevention''; RFA-CE-24-029--``Grants to
Support New Investigators in Conducting Research Related to Preventing
Interpersonal Violence Impacting Children and Youth''; and RFA-CE-24-
034--``Rigorous Evaluation of Policies for their Impacts on the Primary
Prevention
[[Page 24004]]
of Multiple Forms of Violence.'' Agenda items are subject to change as
priorities dictate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-07300 Filed 4-4-24; 8:45 am]
BILLING CODE 4163-18-P
